extended EudraVigilance Medicinal Product Dictionary (XEVMPD) e-learning

Similar documents
EudraVigilance Components & Functionality Introduction

extended EudraVigilance Medicinal Product Dictionary (XEVMPD) Data-Entry Tool (EVWEB) user manual

EudraVigilance Release Notes v.1.13

extended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step Guide

extended EudraVigilance Medicinal Product Dictionary (XEVMPD) Step-by-Step Guide

Measures for Article 57 Data Quality Assurance

IAM2 training documentation

The launch of the new EudraVigilance System

Process description for managing duplicates in the context of the Medical Literature Monitoring (MLM) service

Cover note on XEVMPD substance controlled vocabulary following the quality control exercise

European Medicines Agency Standard Operating Procedure

EudraVigilance - EVWEB User Manual

Guidance for registration with EudraVigilance Veterinary

EudraVigilance support guide

Session 4. Workshop on the implementation of ISO standard for ICSRs. Testing with EMA new process

EU Individual Case Safety Report (ICSR) 1 Implementation Guide

PMS Iteration 1: analysis of the data efforts & value results and recommendation on the scope

Monitoring of Scientific Literature

EudraVigilance - EVWEB User Manual

Guidance for the format and content of the final study report of non-interventional post-authorisation safety studies

Chapter 5: Extended EudraVigilance Product Report Acknowledgement Message

Version number: Published: Date of coming into force:

CREATING A SAFETY MESSAGE STEP-BY-STEP GUIDE

Standard operating procedure

New functionalities in support of the medical literature monitoring service

IRIS Quick guide to registration

PHARMACOVIGILANCE AZANTA

esubmissions Web UI Release Notes

INTERNATIONAL COUNCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE

CDISC in Europe. CDISC Interchange Japan, Tokyo, July 20, 2010

Zambia Medicines Regulatory Authority APPLICATION FOR MARKETING AUTHORISATION OF A MEDICINE FOR HUMAN USE

European Medicines Agency Post-authorisation Evaluation of Medicines for Human Use

esubmissions Web UI Release Notes

Standard operating procedure

Standard Operating Procedure. SOP full title: Sponsor processes for reporting Suspected Unexpected Serious Adverse Reactions

Annex IX: E-SUBMISSION THROUGH THE COMMON EUROPEAN PORTAL (CESP)

Title: Key activities when screening the electronic Reaction Monitoring Reports (ermrs) for new signals

MedDRA Update. MedDRA Industry User Group Meeting. 28 September 2018

WHODrug B3- and C3-formats

CREATING AND SENDING ACKNOWLEDGMENT MESSAGES STEP-BY-STEP GUIDE

EUROPEAN MEDICINES AGENCY (EMA) CONSULTATION

1. STRATEGIC PLANNING

ANSM 11/ Page 1 sur 6

VigiFlow. User Guide. for version 5.2. Consult release notes for updates in 5.3

Standard operating procedure

Standard operating procedure

Comments received from public consultation on good pharmacovigilance practices (GVP)

QP Current Practices, Challenges and Mysteries. Caitriona Lenagh 16 March 2012

MedDRA Version Updates. MedDRA trademark is owned by IFPMA on behalf of ICH

On-boarding of users to SPOR data services

REVISION OF THE ICH GUIDELINE ON CLINICAL SAFETY DATA MANAGEMENT DATA ELEMENTS FOR TRANSMISSION OF INDIVIDUAL CASE SAFETY REPORTS E2B(R3)

The impact of openmedicine findings for standardization

Investigator Activities Quick Reference Guide. Sanofi/Genzyme October 2013

Practical User Guide for Electronic Application Forms (eaf) for human and veterinary medicinal products in the EU

NHS Connecting for Health Programme NPFIT Document Record ID Key Sub-Prog / Project. dm+d

VigiFlow introduction and data entry

MEDICINES CONTROL COUNCIL

VARIATION FILING PROCEDURE IN EUROPE: A COMPLETE REVIEW

MANUAL OF SUBMISSION OF APPLICATIONS FOR CERTIFICATES OF A PHARMACEUTICAL PRODUCT WHO MODEL AND STATEMENTS OF PHARMACEUTICAL PRODUCTS

esubmission Gateway and Web Client Training on the use of XML delivery files for Veterinary submissions

Standard Operating Procedure. SOP effective: 06 February 2017 Review date: 06 February 2019

Guideline on good pharmacovigilance practices (GVP)

Introduction to the Points to Consider Documents. MedDRA trademark is owned by IFPMA on behalf of ICH

3 September

Version Control of Study Specific Documents

LiiV Handbook. Version 2.1. Supplier information in the VARA register. This handbook describes pharmaceutical companies work in LiiV

Pre-notification check for type IB Variations 1

The Lilly Safety Mailing Process

Oracle Argus Interchange

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting

Serious Adverse Events Reporting Form Completion Guidelines

Session 2 ISO ICSR Implementation Technical Aspects - Part 1

SAR SIMPLE AND ADVANCED QUERIES STEP-BY-STEP GUIDE

1 2 December esubmissions? 1. How can baseline dossiers support global esubmissions? Disclaimer. What is a baseline submission?

ENCePP Code of Conduct Implementation Guidance for Sharing of ENCePP Study Data

Oracle Health Sciences Adverse Event Integration Pack for Oracle Health Sciences InForm and Oracle Argus Safety

Date: May 19, Dear Dr. Domingo,

VigiSearch/VigiMine. Magnus Wallberg. November 24 th 2009 Dar Es Salaam, Tanzania.

eaf Release Notes The most recent release appears first. Table of Contents Version (Release Date: 28/09/2018)... 7

eaf Release Notes The most recent release appears first. Table of Contents Version (Release Date: 13/07/2018)... 7

SmPC and. & New QRD. Spanish Medicines Agency (AEMPS)

E2B(R3) Electronic Transmission of Individual Case Safety Reports (ICSRs) Implementation Guide Data Elements and Message Specification

SUBMISSION OF COMMENTS ON

MedDRA BEST PRACTICES. Maintenance and Support Services Organization s (MSSO) Recommendations for Implementation and Use of MedDRA

IVDR Breakout. Copyright 2017 BSI. All rights reserved.

Oracle Argus Interchange

MEDICINES CONTROL COUNCIL

Oracle Argus Interchange

Lead Author Approver Effective Date: 13-MAR-13 Name: Ana Rodriguez Sanchez Review Date: 13-MAR-16

ICH E2B(R3) Expert Working Group. Backwards and Forwards Compatibility

Common Protocol Template (CPT) Frequently Asked Questions

PSUR Repository and the EU single assessment

User Guidance for submissions via esubmission Gateway / Web Client using xml delivery files

Managing Product Master Data

ECHA -term User Guide

Case Study Update on Structured Content Approaches at Genzyme

Q&A QP Declaration. Table of contents

How to send submissions via the Web Client

IRIS Quick guide to the portal for Orphan Industry users

CTI BioPharma Privacy Notice

Transcription:

extended EudraVigilance Medicinal Product Dictionary (XEVMPD) e-learning Session 3: Database Architecture Version 5.3 An agency of the European Union

Roles of the XEVMPD in the EV System (1) The roles of the XEVMPD in the EudraVigilance system are: to create a list of all medicinal products authorised in the EU including medicines authorised centrally via the European Medicines Agency and medicines authorised by regulatory authorities in EU Member States; to create a list of investigational medicinal products studied in clinical trials in the EU; to identify medicines accurately, especially medicines included in reports of suspected adverse reactions; allow for the coding of medicinal products and/or active substance(s) in Individual Case Safety Reports (ICSRs) transmitted to EudraVigilance; 1

Roles of the XEVMPD in the EV System (2) facilitate signal detection and data analysis in the EV Data Warehouse and Analysis System (EVDAS) by using coded medicinal product information; coordinate the regulation safety-monitoring and pharmacovigilance activities of medicines across the EU; and support the implementation of the EudraVigilance Access Policy. 2

XEVMPD I. DATABASE ARCHITECTURE II. PRODUCT REPORT DB III. SCIENTIFIC DB IV. PRODUCT INDEX V. DATA COLLECTION 3

XEVMPD: Data architecture (1) 4

XEVMPD: Data architecture (2) 5

XEVMPD: Data architecture (3) EudraVigilance System: 6

XEVMPD I. DATABASE ARCHITECTURE II. PRODUCT REPORT DATABASE III. SCIENTIFIC DATABASE IV. PRODUCT INDEX V. DATA COLLECTION 7

XEVMPD: Product report database (1) EudraVigilance System 8

XEVMPD: Product report database (2) The product report database collects: authorised medicinal products (AMP); development medicinal products (DMP); approved substances (AS); development substances (DS). 9

XEVMPD: Product report database (3) Other look-up tables in the product report database that can be updated by MAHs and/or sponsors include: organisations (MAH/sponsor); pharmacovigilance system master file locations (PSMFLs); sources; terminology (proposed or development only; standard terminology is maintained by the European Medicines Agency (EMA) including: pharmaceutical dose forms; administration routes; ATC codes. 10

XEVMPD: Product report database (4) Other look-up tables in the product report database that are maintained by the EMA include: authorisation procedures; authorisation status; concentration types; medical devices; substance classes; units of measurement and presentation. If a new term needs to be added on these look-up lists, a request needs to be submitted via the EMA Service Desk portal (https://servicedesk.ema.europa.eu) 11

XEVMPD I. DATABASE ARCHITECTURE II. PRODUCT REPORT DATABASE III. SCIENTIFIC DATABASE IV. PRODUCT INDEX V. DATA COLLECTION 12

XEVMPD: Scientific product database (1) The scientific product database: is designed to support data analysis using a scientific abstraction of the medicinal product information (AMPs and DMPs); implements a hierarchic structure that allows the classification and grouping of all medicinal products available in the XEVMPD on the basis of the active ingredient(s), the strength(s) and the pharmaceutical dose form(s); allows grouping of medicinal products solely on the basis of their composition, independently from trade names and specific marketing-authorisation holders or sponsors. 13

XEVMPD: Scientific product database (2) EudraVigilance System: 14

XEVMPD: Scientific product database (3) 15

XEVMPD: Scientific product database (4) 16

XEVMPD: Scientific product database (5) 17

XEVMPD: Scientific product database (6) 18

XEVMPD I. DATABASE ARCHITECTURE II. PRODUCT REPORT DB III. SCIENTIFIC DB IV. PRODUCT INDEX V. DATA COLLECTION 19

XEVMPD: Product index database (1) EudraVigilance System: 20

XEVMPD: Product index database (2) 21

XEVMPD: Product index database (3) 22

Product index and validation process (1) The product index is used as a reference for the validation of the product name in the following fields (*) of the ICH E2B(R2) ICSR: PATIENT PAST DRUG THERAPY SECTION; B.1.8a patient drug name PARENT PAST DRUG THERAPY SECTION; B.1.10.8a parent drug name DRUG SECTION; B.4.k.2.1 medicinal product name DRUG SECTION; B.4.k.2.2 active substance (*) EudraVigilance Human - Processing of Safety Messages and Individual Case Safety Reports (ICSRs) 23

Product index and validation process (2) If the information in the patient drug name (B.1.8a), parent drug name (B.1.10.8a) medicinal product name (B.4.k.2.1) and active ingredient (B.4.k.2.2) fields are: Validated NOT validated ICH ICSR loaded (Acknowledgment 01) Generation of a Warning ICH ICSR loaded (Acknowledgment 01 with Warning) 24

XEVMPD: Data architecture and validation (1) 25

XEVMPD: Data architecture and validation (2) 26

XEVMPD: Data architecture and validation (3) 27

XEVMPD: Data architecture and validation (4) 28

XEVMPD: Data architecture and validation (5) 29

XEVMPD: Data architecture and validation (6) 30

XEVMPD: Data architecture and validation (7) 31

XEVMPD: Data architecture and validation (8) 32

XEVMPD: Data architecture and validation (9) 33

XEVMPD: Data architecture and validation (10) 34

XEVMPD I. DATABASE ARCHITECTURE II. PRODUCT REPORT DB III. SCIENTIFIC DB IV. PRODUCT INDEX V. DATA COLLECTION 35

XEVMPD: Data collection 36

Data collection tools Insert and maintain information in the XEVMPD: EV WEB tool (as of April 2012); exchange of XML files: extended Eudravigilance Medicinal Product Reports (XEVPRMs). 37

XEVMPD: Data collection Insert and Maintain: 38

Data entry and maintenance User rights: * Except if they register a virtual affiliate as a WebTrader under the headquarter profile in EV 39

1. XEVMPD Data Entry Tool (EVWEB) The XEVMPD data entry tool (EVWEB) application offers the possibility to manually create an XEVPRM and to send it to the XEVMPD. The EVWEB tool can also be used for maintaining the information already entered in the XEVMPD. A part from the data collection process, the EVWEB tool can be used to access and query the XEVMPD. 40

2. Exchange of XML files An organisation (MAH or Sponsor) can exchange XML files with the XEVMPD in order to insert and maintain the information in the XEVMPD. The XML files are defined as extended EudraVigilance Product Report Messages (XEVPRMs). Organisation Medicinal Product Dictionary XEVPRM (XML) XEVPRM ACK (XML) EudraVigilance Medicinal Product Dictionary 41

XEVMPD: Data collection summary 42

XEVPRM Acknowledgement With all three tools, the user always sends a XEVPRM to the XEVMPD Where can the user find the acknowledgement? * Except if they register a virtual affiliate as a WebTrader under the headquarter profile in EV 43